Mitsubishi UFJ Trust & Banking’s NeoGenomics NEO Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$136K	Buy	+9,312	New	+$89.9K	﹤0.01%	1443

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

HCA

Harbor Capital Advisors Chicago, Illinois $1.47B AUM 42.58% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's NEO Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in NeoGenomics (NEO) in Q2 2026: 9,312 shares worth $136K. The stake represents ﹤0.01% of the portfolio and ranks #1443 among its holdings.

95 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

Mitsubishi UFJ Trust & Banking held 9,312 shares of NeoGenomics worth $136K as of Q2 2026.
NeoGenomics was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
NeoGenomics made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1443 holding.
95 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.